M R Silver
Overview
Explore the profile of M R Silver including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Silver M, Geronemus R, Krause M, Chen C, Kewalramani R, Stehman-Breen C
Curr Med Res Opin
. 2009 Feb;
25(1):123-31.
PMID: 19210145
Objective: To evaluate the efficacy and safety of darbepoetin alfa dosed every-other-week (Q2W) to treat anemia in subjects with chronic kidney disease (CKD), not receiving dialysis, who were naïve to...
2.
Agarwal A, Silver M, Reed J, Dhingra R, Liu W, Varma N, et al.
J Intern Med
. 2006 Nov;
260(6):577-85.
PMID: 17116009
Objective: To demonstrate the efficacy and safety of once-monthly (QM) darbepoetin alfa administration in maintaining haemoglobin (Hb) 11.0-13.0 g dL(-1) in subjects with chronic kidney disease (CKD) not receiving dialysis...
3.
Silver M, Sower S
J Mol Endocrinol
. 2006 May;
36(3):601-10.
PMID: 16720727
The recently cloned lamprey GnRH receptor was shown to have several unique features, including the longest intracellular C-terminal tail (120 amino acids (aa)) of any previously described GnRH receptor. In...
4.
Cohen E, Elpern E, Silver M
Chest
. 2001 Sep;
120(3):1024-6.
PMID: 11555544
Pulmonary alveolar proteinosis is characterized by the accumulation of proteinaceous material in the alveoli leading to varying degrees of impairment in gas exchange. Generally, the degree of hypoxemia is mild,...
5.
Silver M, CAIN J
Adv Ren Replace Ther
. 2000 Oct;
7(4 Suppl 1):S45-55.
PMID: 11053587
Problems with vascular access for hemodialysis patients contribute substantially to the morbidity, mortality, and high costs associated with renal replacement therapy. Data from the Network 9/10 Regional Hemodialysis Vascular Access...
6.
Seneff M, Wagner D, Thompson D, Honeycutt C, Silver M
Crit Care Med
. 2000 Mar;
28(2):342-50.
PMID: 10708164
Objectives: To compare the 6-month mortality rate of chronically ventilated patients treated either exclusively in a traditional acute-care hospital or transferred during hospitalization to a long-term acute-care facility. To analyze...
7.
Sehgal A, Silver M, Covinsky K, Coffin R, CAIN J
Am J Kidney Dis
. 2000 Feb;
35(2):275-81.
PMID: 10676727
The type of hemodialysis vascular access (catheter, fistula, graft) is an important determinant of patient morbidity and dialysis efficiency. The relative importance of patient versus provider factors in determining type...
8.
9.
Sehgal A, Snow R, Singer M, Amini S, DeOreo P, Silver M, et al.
Am J Kidney Dis
. 1998 Apr;
31(4):593-601.
PMID: 9531174
Mortality rates among American hemodialysis patients are the highest in the industrialized world. Measures of delivered dialysis (Kt/V) correspond strongly with survival and are estimated to be inadequate in one...
10.
DeCoursey T, Kim S, Silver M, Quandt F
J Membr Biol
. 1996 Jul;
152(2):141-57.
PMID: 9139125
Ion channel expression was studied in THP-1 human monocytic leukemia cells induced to differentiate into macrophage-like cells by exposure to the phorbol ester, phorbol 12-myristate 13-acetate (PMA). Inactivating delayed rectifier...